China Closes In On US As Biggest Healthcare Market
China overtook Japan as the world’s second-biggest healthcare market in 2013, and with its annual healthcare spending forecast to reach nearly US$900bn by 2018, it will rapidly close the gap on the US, reports the Economist Intelligence Unit (EIU).
China overtook Japan as the world’s second-biggest healthcare market in 2013, and with its annual healthcare spending forecast to reach nearly US$900bn by 2018, it will rapidly close the gap on the US, reports the Economist Intelligence Unit (EIU).
EIU’s China Healthy Province Index (CHPI) provides a detailed healthcare profile of each of China’s 31 provinces,ranking provinces according to which are best placed in terms of resources and financing to meet current and anticipated healthcare demand. Beijing tops the CHPI, but one of the surprising outcomes was the strong performance of poorer provinces such as Qinghai and Gansu. Sparse populations in such regions ease pressure on local healthcare systems. Those that bottomed out include the rapidly developing central provinces of Henan and Anhui, densely populated regions where access to healthcare and funding is low despite booming local demand.
The EIU also reports how the Chinese government has been opening up the healthcare system to private sector investment, but warns that stresses in the system our mounting, as popular frustration over costs and access begins to “boil over”.
More information: http://www.eiu.com/chpi2014
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
